Tandem Diabetes Care (TNDM) Return on Capital Employed (2014 - 2026)
Tandem Diabetes Care posted quarterly Return on Capital Employed of 10.89% for Q1 2026, up 1626.0% year-on-year from 0.63% in Q1 2025, and up 63.05% on a QoQ basis from 29.48% in Q4 2025.
Tandem Diabetes Care (TNDM) has 13 years of Return on Capital Employed data on file, last reported at 10.89% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 1626.0% year-over-year to 10.89%; the trailing twelve-month figure through Mar 2026 stood at 10.89% (up 1626.0% YoY), and the FY2025 full-year result was 27.47%, down 1357.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 10.89%, up from 29.48% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 1.27% in Q1 2022 and bottomed at 31.5% in Q3 2025.
- The 5-year median for Return on Capital Employed is 19.9% (2024), against an average of 19.64%.
- The widest annual swing landed in 2023, when Return on Capital Employed plunged 2909 bps; it then surged 1720 bps in 2024.
- A 5-year view of Return on Capital Employed shows it stood at 10.49% in 2022, then tumbled by 196 bps to 31.05% in 2023, then jumped by 55 bps to 13.85% in 2024, then slumped by 113 bps to 29.48% in 2025, then soared by 63 bps to 10.89% in 2026.
- The last three Return on Capital Employed figures came in at 10.89% (Q1 2026), 29.48% (Q4 2025), and 31.5% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn | -10.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.89% |
| Dec 31, 2025 | -29.48% |
| Sep 30, 2025 | -31.50% |
| Jun 30, 2025 | -30.80% |
| Mar 31, 2025 | -27.15% |
| Dec 31, 2024 | -13.85% |
| Sep 30, 2024 | -19.41% |
| Jun 30, 2024 | -19.90% |
| Mar 31, 2024 | -19.51% |
| Dec 31, 2023 | -31.05% |
| Sep 30, 2023 | -28.56% |
| Jun 30, 2023 | -29.89% |
| Mar 31, 2023 | -24.67% |
| Dec 31, 2022 | -10.49% |
| Sep 30, 2022 | -7.18% |
| Jun 30, 2022 | -0.80% |
| Mar 31, 2022 | 1.27% |
| Dec 31, 2021 | 3.04% |
| Sep 30, 2021 | 4.06% |
| Jun 30, 2021 | 2.98% |
| Mar 31, 2021 | 0.38% |
| Dec 31, 2020 | -1.35% |
| Sep 30, 2020 | -4.54% |
| Jun 30, 2020 | -8.06% |
| Mar 31, 2020 | -8.21% |
| Dec 31, 2019 | -7.96% |
| Sep 30, 2019 | -10.55% |
| Jun 30, 2019 | -18.59% |
| Mar 31, 2019 | -30.00% |
| Dec 31, 2018 | -34.96% |
| Sep 30, 2018 | -49.24% |
| Jun 30, 2018 | -47.99% |
| Mar 31, 2018 | -74.96% |
| Dec 31, 2017 | -113.26% |
| Sep 30, 2017 | -104.48% |
| Jun 30, 2017 | -109.58% |
| Mar 31, 2017 | -96.04% |
| Dec 31, 2016 | -111.68% |
| Sep 30, 2016 | -116.92% |
| Jun 30, 2016 | -75.37% |
| Mar 31, 2016 | -69.32% |
| Dec 31, 2015 | -68.94% |
| Sep 30, 2015 | -66.86% |
| Jun 30, 2015 | -58.26% |
| Mar 31, 2015 | -67.16% |
| Dec 31, 2014 | -80.99% |
| Sep 30, 2014 | -69.33% |
| Jun 30, 2014 | -55.08% |
| Mar 31, 2014 | -45.34% |